Skip to main content

Table 2 Perioperative and oncologic outcomes

From: Predictors of mortality within the first year post-hepatectomy for hepatocellular carcinoma

  Number (n = 163)
Tumor size (mm), median (range) 40 (1 – 200)
Macrovascular invasion 18 (11%)
Microvascular invasion 47 (28.8%)
Pringles maneuver used 27 (16.6%)
Competing interests Competing interests
 Major resection 74 (45.4%)
 Right hemihepatectomy 37 (50%)
 Left hemihepatectomy 21 (28.4%)
 Right trisectionectomy 12 (16.2%)
 Left trisectionectomy 1 (1.4%)
 Central hepatectomy 3 (4%)
 Minor resection 89 (54.6%)
Laparoscopic resection 101 (62%)
Multifocal (≥ 2) tumors 43 (26.4%)
Giant (≥ 10 cm) tumor 32 (19.6%)
Blood transfusion 30 (18.4%)
Pneumonia 14 (8.6%)
Acute renal failure 7 (4.3%)
Urinary tract infection 6 (3.7%)
Pulmonary embolism 1 (0.6%)
Intra-abdominal abscess 4 (2.5%)
Bile leak 3 (1.8%)
Superficial surgical site infection 7 (4.3%)
Post-hepatectomy liver failure 1 (50–50 criteria) 6 (3.7%)
Post-hepatectomy liver failure 2 (peak serum bilirubin criteria) 7 (4.3%)
Post-hepatectomy liver failure 3 (ISGLS criteria) 25 (15.3%)
30-Day mortality 6 (3.7%)
90-Day mortality 8 (4.9%)
One-year mortality 15 (9.2%)
  1. ISGLS International Study Group on Liver Surgery